ATRICURE INC (ATRC) Stock News

USA - Nasdaq - NASDAQ:ATRC - US04963C2098 - Common Stock

41.04 USD

-1.34 (-3.16%)

Last: 12/15/2025, 4:30:01 PM

41.04 USD

0 (0%)

After Hours: 12/15/2025, 4:30:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ATRC Latest News, Press Relases and Analysis

All

Press Releases

4 days ago - By: AtriCure, Inc.

AtriCure Announces the First Patients Treated with Novel Dual Energy Platform

7 days ago - By: Zacks Investment Research - Mentions: BSX

Are Medical Stocks Lagging AtriCure (ATRC) This Year?

16 days ago - By: The Motley Fool

Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?

2 months ago - By: Benzinga - Mentions: CGO ROL ESRT NNBR ...

Earnings Scheduled For October 29, 2025

5 months ago - By: The Motley Fool

AtriCure (ATRC) Q2 Revenue Jumps 17%

25 days ago - By: Zacks Investment Research - Mentions: CDTX

Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?

a month ago - By: AtriCure, Inc.

AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference

a month ago - By: Zacks Investment Research

AtriCure (ATRC) Loses 13.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

a month ago - By: Zacks Investment Research

Here's What Key Metrics Tell Us About AtriCure (ATRC) Q3 Earnings (Revised)

8 months ago - By: Benzinga

14 Analysts Assess AtriCure: What You Need To Know

a month ago - By: Zacks Investment Research - Mentions: CABA

Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year?

2 months ago - By: Zacks Investment Research

Here's What Key Metrics Tell Us About AtriCure (ATRC) Q3 Earnings

2 months ago - By: Zacks Investment Research

AtriCure (ATRC) Reports Q3 Loss, Beats Revenue Estimates

2 months ago - By: AtriCure, Inc.

AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025

2 months ago - By: AtriCure, Inc.

AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial

2 months ago - By: AtriCure, Inc.

AtriCure to Participate in Upcoming Investor Conferences

2 months ago - By: AtriCure, Inc.

AtriCure to Announce Third Quarter 2025 Financial Results

3 months ago - By: AtriCure, Inc.

AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following Amputation

4 months ago - By: AtriCure, Inc.

AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference

5 months ago - By: AtriCure, Inc.

AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025

5 months ago - By: AtriCure, Inc.

AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference

5 months ago - By: AtriCure, Inc.

AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention

5 months ago - By: AtriCure, Inc.

AtriCure to Announce Second Quarter 2025 Financial Results

7 months ago - By: Zacks Investment Research

Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?

7 months ago - By: AtriCure, Inc.

AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

7 months ago - By: Zacks Investment Research

Does AtriCure (ATRC) Have the Potential to Rally 54.7% as Wall Street Analysts Expect?